XiFin Introduces Empower AI for Specialty Pharmacy at Asembia AXS26 and Unveils New Specialty Pharmacy Research Findings

New AI-driven RCM capabilities address rising reimbursement complexity, with new Specialty Pharmacy Transformation survey findings underscoring growing demand for intelligent automation

XiFin, Inc., a leader in AI-driven revenue cycle management (RCM) solutions, today announced the introduction of XiFin® Empower AI for Specialty Pharmacy at Asembia’s AXS26 Summit (booth #1909), delivering a new approach to managing the growing complexity of specialty pharmacy revenue cycle operations.

As pharmacies expand specialty therapy offerings, clinical services, and other revenue opportunities, they are increasingly challenged by shifting payor policies, the complexity of medical benefit reimbursement, and mounting administrative burden. XiFin Empower AI is designed to address these challenges by bringing intelligence directly into revenue cycle workflows and helping organizations move beyond manual, fragmented processes toward more coordinated and efficient AI-driven operations.

Delivering Intelligence to Specialty Pharmacy Revenue Operations

At the center of XiFin’s AXS26 presence is XiFin^® Empower AI, an interoperable AI ecosystem designed to work across revenue cycle workflows—not just to automate tasks, but to help coordinate smarter outcomes.

Rather than layering AI on top of existing inefficiencies, XiFin is demonstrating how intelligence can be applied within and beyond specialty pharmacy workflows to support processes from intake and eligibility through denial management and appeals to improve efficiency and financial performance.

Empower AI enables specialty pharmacies to:

• Reduce manual effort by automating high-friction processes
• Prioritize work intelligently based on financial and operational impact
• Improve consistency and accuracy across reimbursement workflows
• Scale operations without increasing risk or administrative burden

“Our survey findings show that as specialty pharmacies expand clinically, reimbursement complexity, particularly on the medical benefit side, is becoming a defining operational challenge,” said David Pope, PharmD, Chief Pharmacy Officer at XiFin. “Empower AI brings intelligence into the workflow—helping organizations simplify medical billing, reduce administrative burden, and improve both financial performance and patient access to specialty therapies.”

New Specialty Pharmacy Transformation Survey Findings Reinforce Need for AI-Driven RC

At ASX26, XiFin is also releasing findings from its 2026 Specialty Pharmacy Transformation Outlook survey, which highlight the operational pressures driving demand for more intelligent revenue cycle solutions. The findings indicate:

• Strong growth outlook driven by expanding clinical role:
  • More than two-thirds (68%) of respondents identified an expanded role for pharmacists to fill care gaps as the top growth opportunity, which was also noted in the 2025 survey.
• Continued expansion into high-complexity therapies:
  • In the next 12 to 36 months, participants plan to expand into treatments for growth deficiency, pulmonary hypertension, infertility, hemophilia, immune deficiency, and cystic fibrosis.
  • 48% reported an increase in revenue as they expanded their specialty pharmacy offering, up from 38% in 2025.
• Reimbursement and operational complexity intensifying:
  • Low medication reimbursement ranked as a key challenge, followed closely by workload and time constraints.
  • Medical billing reimbursement ranked as the third-highest challenge, moving up from the 11th spot from the previous year, demonstrating the growing medical billing complexity that pharmacies are experiencing.
  • 62% of respondents ranked technology, automation, and AI as a top priority as they seek to improve operational efficiency and relieve staff pressure.

Together, these findings point to a clear shift: as specialty pharmacies expand clinically, managing reimbursement complexity requires a more intelligent and adaptive revenue cycle infrastructure. Pharmacies must act with urgency to expand patient access and affordability.

Experience Empower AI at Asembia AXS26

At booth #1909, XiFin will showcase real-world applications of Empower AI in specialty pharmacy RCM. XiFin invites specialty pharmacy attendees to:

• Explore real-world applications of AI in RCM workflows
• Witness a live demo of XiFin Empower AI Agents and discuss prior authorization
• Discuss emerging trends and payor dynamics
• Identify opportunities to improve efficiency, predictability, and financial performance

Access the full survey at www.xifin.com/specialty-report or visit XiFin at booth #1909 during Asembia AXS26 to explore the findings and see Empower AI in action.

About XiFin

XiFin is a healthcare information technology company that empowers organizations to navigate an evolving and increasingly complex healthcare landscape. The XiFin Empower AI RCM ecosystem and trusted data employ active intelligence and automation to reduce manual touches, coordinate workflows, accelerate customer innovation, and improve financial outcomes. Our comprehensive set of solutions—spanning revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement—deliver The Power to Do Good® so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.